Yoram Palti is CTO at NovoCure Ltd (NVCR). They have made 19 open-market trades across 1 company since 2017, most recently 2018-08-28.
CIK 0001654403
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 1,041,054 | $15.2M |
Shares reported on the most recent Form 4, priced at the 2018-08-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL | 2018-08-28 | 2018-08-30 | $40.27 | $349K | +8.9% | +21.7% | -24.1% |
| NVCR | SELL | 2018-08-24 | 2018-08-28 | $40.03 | $1.6M | +12.1% | +28.5% | -24.3% |
| NVCR | SELL | 2018-06-15 | 2018-06-19 | $31.09 | $933K | -2.2% | +16.6% | +44.8% |
| NVCR | SELL | 2018-06-14 | 2018-06-15 | $31.64 | $949K | +1.5% | +15.4% | +58.8% |
| NVCR | SELL | 2018-04-26 | 2018-04-30 | $26.19 | $936K | +8.6% | +15.9% | +22.8% |
| NVCR | SELL | 2018-04-23 | 2018-04-25 | $25.07 | $892K | +18.3% | +27.8% | +52.8% |
| NVCR | SELL | 2018-04-19 | 2018-04-23 | $24.98 | $2.5M | +12.0% | +19.2% | +53.2% |
| NVCR | SELL | 2018-04-17 | 2018-04-19 | $23.76 | $1.4M | +11.1% | +18.9% | +46.9% |
| NVCR | SELL | 2018-04-04 | 2018-04-05 | $19.89 | $597K | +14.5% | +38.4% | +62.6% |
| NVCR | SELL | 2018-04-02 | 2018-04-04 | $20.37 | $1.8M | +5.1% | +36.6% | +57.8% |
| NVCR | SELL | 2018-03-29 | 2018-04-02 | $21.67 | $650K | +7.1% | +35.7% | +56.5% |
| NVCR | SELL | 2017-11-13 | 2017-11-14 | $17.13 | $1.0M | +5.4% | +13.4% | +16.5% |
| NVCR | SELL | 2017-11-08 | 2017-11-13 | $18.66 | $2.8M | +10.8% | +17.3% | +19.9% |
| NVCR | SELL | 2017-11-06 | 2017-11-08 | $21.06 | $1.3M | -4.5% | +6.6% | +12.4% |
| NVCR | SELL | 2017-11-02 | 2017-11-06 | $21.72 | $1.3M | -13.1% | -6.5% | -0.5% |
| NVCR | SELL | 2017-06-05 | 2017-06-06 | $13.82 | $106K | +9.6% | +32.6% | +42.6% |
| NVCR | SELL | 2017-06-01 | 2017-06-05 | $13.27 | $106K | +9.2% | +33.0% | +41.0% |
| NVCR | SELL | 2017-05-30 | 2017-06-01 | $12.49 | $100K | +14.0% | +33.6% | +52.8% |
| NVCR | SELL | 2017-05-25 | 2017-05-30 | $12.88 | $103K | +21.4% | +36.1% | +59.9% |
| NVCR | SELL · 10b5-1 | 2017-05-24 | 2017-05-25 | $13.15 | $53K | +5.8% | +34.7% | +48.6% |
| NVCR | SELL · 10b5-1 | 2017-05-22 | 2017-05-24 | $11.74 | $94K | +1.5% | +28.6% | +42.5% |
| NVCR | SELL · 10b5-1 | 2017-05-18 | 2017-05-22 | $11.39 | $91K | +15.2% | +47.7% | +59.5% |
| NVCR | SELL · 10b5-1 | 2017-05-17 | 2017-05-18 | $11.47 | $46K | +11.1% | +39.8% | +77.0% |
| NVCR | SELL · 10b5-1 | 2017-05-15 | 2017-05-17 | $12.05 | $96K | +11.1% | +31.6% | +71.1% |
| NVCR | SELL · 10b5-1 | 2017-05-11 | 2017-05-15 | $11.79 | $94K | +7.4% | +23.0% | +56.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.